Angel Therapeutics is a global biotechnology company headquartered in the San Francisco Bay Area. Our mission is to develop competitive innovative biotherapeutics to improve the lives of cancer patients. Our Vision is to become one of the global leading companies in research & development of monoclonal antibody and Fc-fusion protein therapeutics.

At Angel Therapeutics we have pioneered a unique way of discovering and developing biotherapeutics.  Our approach is aimed primarily on oncology and immuno-oncology cancer therapeutics – Antibodies. Our discovery platform leverages modern drug discovery technologies and state-of-the-art biologics innovation techniques to identify therapeutic agents that can address unmet medical needs world-wide.

Angel Therapeutics focuses on four therapeutic areas: oncology, bone health, nephrology, and inflammation.